Cipher Pharmaceuticals Inc

Type: Company
Name: Cipher Pharmaceuticals Inc
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment Conference

MISSISSAUGA, ON, Sept. 3, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced Shawn Patrick O'Brien, President and Chief Executive Officer, is presenting at the Rodman & Renshaw 16th Annual Global Investment ... [Published Canada NewsWire - Sep 03 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Shawn Patrick O???Brien , President & CEO Of Cipher Pharmaceuticals On BNN

Shawn Patrick O’Brien, President & CEO Of Cipher Pharmaceuticals (DND.TO) On BNN ... [Published BioSpace - Aug 21 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 1 reports

Ranbaxy to market Cipher Pharma's isotretinoin capsules in Brazil

Cipher Pharmaceuticals Inc. a Mississauga, Ontario-based growing specialty pharmaceutical company, has entered into a definitive distribution and supply agreement with Ranbaxy Laboratories Ltd. (Ranbaxy) under which Cipher has granted Ranbaxy the exclusive ... [Published PharmaBiz - Jul 24 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Ipca halts drug exports to US

Mumbai, July 24: Ipca Laboratories today said it was voluntarily suspending shipments of drug ingredients from one of its plants in the country, following concerns expressed by the US Food and Drug Administration (FDA). The mid-sized company said the ... [Published Calcutta Telegraph - Jul 25 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Cipher, Andrómaco ink supply agreement for isotretinoin capsules in Chile

Canada-based Cipher Pharmaceuticals has entered into a definitive distribution and supply agreement with Laboratorios Andrómaco (Andrómaco) for isotretinoin product in Chile. ... [Published PBR - News - Jun 19 2014]

Quotes

...and is a logical choice to commercialize it in Brazil," said Shawn O'Brien, president and chief executive officer of Cipher Pharmaceuticals. "Brazil is the largest isotretinoin market in Latin America, with annual sales exceeding CDN$50 million, and the market has been growing solidly, providing a compelling opportunity for our novel formulation."

More Content

All (6) | News (5) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Cipher Pharmaceuticals Inc. to present at Rodma... [Published Canada NewsWire - Sep 03 2014]
Shawn Patrick O???Brien , President & CEO Of Ci... [Published BioSpace - Aug 21 2014]
Ipca halts drug exports to US [Published Calcutta Telegraph - Jul 25 2014]
Ranbaxy to market Cipher Pharma's isotretinoin ... [Published PharmaBiz - Jul 24 2014]
Cipher, Andrómaco ink supply agreement for isot... [Published PBR - News - Jun 19 2014]
Ranbaxy gets US approval to launch Absorica [Published Topnews.in - May 30 2012]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Cipher, Andrómaco ink supply agreement for isot... [Published PBR - News - Jun 19 2014]
Canada-based Cipher Pharmaceuticals has entered into a definitive distribution and supply agreement with Laboratorios Andrómaco (Andrómaco) for isotretinoin product in Chile. ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.